The Latest Cardiac and Vascular News
Malmö, May 23, 2018 Acarix AB recruits Per Persson as Chief Commercial Officer Acarix AB (publ) (“Acarix”), today announced the recruitment of Per Persson as new Chief Commercial Officer to accelerate the sales execution for the CADScor®System for Coronary Artery Disease (CAD) risk assessment. He has a solid background in […]
SOUTH SAN FRANCISCO, Calif., May 21, 2018 (GLOBE NEWSWIRE) — MyoKardia, Inc. (Nasdaq:MYOK), a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable cardiovascular diseases, today announced that it has commenced a proposed underwritten public offering of 3,750,000 shares of its common stock. All shares of […]
ST. LOUIS, May 22, 2018 (GLOBE NEWSWIRE) — Stereotaxis, Inc. (OTCQX:STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that David Fischel, Chairman and Chief Executive Officer, is scheduled to present at the 8th Annual LD Micro Invitational. Mr. Fischel will provide an […]
SHENZHEN, China–(BUSINESS WIRE)–Splendris International Limited, an affiliate of Shenzhen Salubris Pharmaceuticals Co Ltd. (Salubris), a multi-national leader in the development and commercialization of cardiovascular products in China and beyond, today announced a strategic investment and in-licensing agreement with Swiss cardiovascular pioneer M.A. MedAlliance S.A. (MedAlliance). Under the terms of the […]
PARIS–(BUSINESS WIRE)–Sofinnova Partners, a leading European venture capital firm specialized in Life Sciences, has appointed Dr. Martin T. Rothman as Venture Partner. Dr. Rothman brings forty years of experience and a strong international network in the medical field to Sofinnova Partners. As Venture Partner, Dr. Rothman will focus on helping […]
LAGUNA HILLS, Calif., May 16, 2018 /PRNewswire/ — NeuroVasc Technologies, Inc., a medical device company active in the endovascular field, announced today that it has closed a $6.3MM Series B Preferred Stock financing. The funding includes multiple investors and was led by ShangBay Capital. NeuroVasc Technologies, Inc. is dedicated to improving treatment of […]
REDWOOD CITY, Calif., May 14, 2018 (GLOBE NEWSWIRE) — Avinger, Inc. (Nasdaq:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today reported results for the first quarter ended March 31, 2018. First Quarter and Recent Highlights Revenue of $1.8 million for the first quarter of 2018 Announced […]
VANCOUVER, May 15, 2018 /PRNewswire/ – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies, today announced that its management and board of directors (the “Board”) urge the Company’s shareholders of record to vote “FOR” the proposal authorizing the […]
MARLBOROUGH, Mass., May 14, 2018 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 34th Annual Strategic Decisions Conference on May 31, 2018 in New York. Mike Mahoney, chairman and chief executive officer, will participate in a 50-minute presentation and question-and-answer session with the host analyst beginning at approximately 8:00 a.m. EDT. A live […]
ENGLEWOOD, Colo., May 14, 2018 /PRNewswire/ — Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced that its board of directors approved a program to buy back an additional $2 million of […]
